Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-06 / J Immunother Cancer 2018 Mar;6(1):19Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-03-01 / Front Immunol 2018;9:394Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-1431Anti-cancer vaccine therapy for hematologic malignancies: An evolving era
/in Acute Leukemia, Checkpoint-Inhibitors, Chronic Leukemia, Dendritic Cells, International Publications /von 2018-02-15 / Blood Rev. 2018 Jul;32(4):312-325Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)Efficacy of intracellular immune checkpoint-silenced DC vaccine
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-02-08 / JCI Insight 2018 Feb;3(3)Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes
/in Cervical Cancer, Dendritic Cells, Exosome, International Publications /von 2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-1187Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
/in Dendritic Cells, International Publications /von 2018-02-01 / Trends Cancer 2018 02;4(2):119-137Radiation and Anti-Cancer Vaccines: A Winning Combination
/in Dendritic Cells, International Publications /von 2018-01-30 / Vaccines (Basel) 2018 Jan;6(1)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de